Market Place
Sourcing Support
Drug regulator transfers 95 officials in mass reshuffle
20 Apr 2026 //
ECONOMICTIMES
Theramex exits self-regulatory body after compliance failures
20 Apr 2026 //
FIERCE PHARMA
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
20 Apr 2026 //
INDPHARMAPOST
NGO Urges Drug Regulator to Oversee Nutraceuticals
19 Apr 2026 //
ECONOMICTIMES
FDA Warns Firm For Inappropriate Use Of AI In Drug Manufacturing
17 Apr 2026 //
RAPS
More transparency, evidence needed for accelerated nods: ICER
17 Apr 2026 //
FIERCE PHARMA
Teva, Viatris launch separate recalls in the US
17 Apr 2026 //
FIERCE PHARMA
FDA Cracks Down on Drug Ads with 3 Untitled Letters
15 Apr 2026 //
RAPS
Pfizer Rebuked By FDA For Misleading Adcetris Ads On Facebook
14 Apr 2026 //
FIERCE PHARMA
Indoco Remedies & Panacea Biotec: Key Briefs
14 Apr 2026 //
INDPHARMAPOST
CS Analytical Names Roark as Director of Scientific Affairs
14 Apr 2026 //
PR NEWSWIRE
DCC Reclassifies 4 Drugs from H to H1 for Stricter Controls
13 Apr 2026 //
PHARMABIZ
FDA Boosts Biopharma Accountability With CRL Transparency
13 Apr 2026 //
BIOSPACE
Unichem US Arm Recalls Buspirone After Failed Stability Test
13 Apr 2026 //
INDPHARMAPOST
Ayco Farms Clarifies FDA Enforcement Report Listing
10 Apr 2026 //
BUSINESSWIRE
DTAB Urges Scrapping Draft Ban on Schedule G Drug Ads
10 Apr 2026 //
PHARMABIZ
Amneal, Biocorrx Accused Of `False And Misleading` Promotions
10 Apr 2026 //
FIERCE PHARMA
BIOFIRE SPOTFIRE Revolutionizes Mycoplasma Testing In Pharma
09 Apr 2026 //
PR NEWSWIRE
FDA Warns Texas Medical Spa For Botox Dispensing Discrepancies
09 Apr 2026 //
RAPS
Health officials warn of veterinary sedative in illegal drug
07 Apr 2026 //
REUTERS
Immunitybio Responds To FDA Warning Letter With New Protocols
06 Apr 2026 //
FIERCE PHARMA
Government Ensures Safety Of GLP-1 Drugs Amid Weight-Loss Hype
01 Apr 2026 //
ECONOMICTIMES
Midst Global Headwinds, CDSCO Cracks Down On GLP-1 Gold Rush
01 Apr 2026 //
EXPRESSPHARMA
Panel Urges Timely Actions To Fill CDSCO Vacancies
31 Mar 2026 //
PHARMABIZ
EMA Details Data Quality Considerations When Using RWD
30 Mar 2026 //
RAPS
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Regulator Steps Up Oversight Of GLP-1 Drug Distribution Chain
28 Mar 2026 //
ECONOMICTIMES
Telangana DCA Issues Safety Advisory On Use Of Semaglutide
26 Mar 2026 //
PHARMABIZ
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
Centre Enhances GLP-1 Drug Oversight Due To Concerns Practices
25 Mar 2026 //
ECONOMICTIMES
CSL adds warning to Flucelvax label
25 Mar 2026 //
FIERCE PHARMA
GAO calls on FDA to finalize guidance on adcomm COI
24 Mar 2026 //
RAPS
DCGI Intensifies Crackdown on GLP-1 Drug Misuse, Misleading Ads
24 Mar 2026 //
ECONOMICTIMES
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Immunitybio Hit With FDA Warning Letter Over Anktiva Promotions
24 Mar 2026 //
FIERCE PHARMA
Lilly Plots European Discontinuations Of Certain Insulin Products
24 Mar 2026 //
FIERCE PHARMA
Indian Drugmakers Flood Market With Cheap Ozempic, Wegovy Copies
23 Mar 2026 //
ECONOMICTIMES
India’s drug regulator flags 90 unapproved FDCs
23 Mar 2026 //
ECONOMICTIMES
US FDA flags seizure risk with certain Parkinson`s drugs
21 Mar 2026 //
FDA
Investors Target Pharma QC as Drug Safety Surges
20 Mar 2026 //
PHARMIWEB
Intuitive Recalls Surgical Stapler Reloads After Patient Death
20 Mar 2026 //
FIERCE BIOTECH
CDSCO Urges Slas To Adopt Uniform Licensing Guidance
20 Mar 2026 //
PHARMABIZ
Industry Strengthens Shield Against Counterfeits At TAF 2026
20 Mar 2026 //
PHARMABIZ
ASCP Endorses Reforms After OIG Antipsychotic Reports
20 Mar 2026 //
PHARMIWEB
CDSCO Requests SLAs To Revoke Approval For Sodium Hyaluronate
20 Mar 2026 //
PHARMABIZ
FDA Warns Indian And German Firms For GMP, BIMO Violations
19 Mar 2026 //
RAPS
DentaBiome Issues 2026 Oral Postbiotic Consumer Warning Report
17 Mar 2026 //
GLOBENEWSWIRE
Health Ministry Amends D&C Rules To Mandate PACs Submission
16 Mar 2026 //
PHARMABIZ
KSRPO alerts state FDA about spurious drugs sold by fake doctor
16 Mar 2026 //
PHARMABIZ
DTAB Recommends Exemptions From Revised Schedule M Norms
16 Mar 2026 //
PHARMABIZ
TNHDA Urges Major Drug Regulatory Reforms After Coldrif Cough
16 Mar 2026 //
PHARMABIZ
APL Healthcare`s Unit-IV Classified As VAI By The USFDA
14 Mar 2026 //
INDPHARMAPOST
India`s Drug Quality Surveillance Surpasses 500K Samples Tested
13 Mar 2026 //
PHARMABIZ
CDSCO Advises Against Promoting Prescription Obesity Drugs
12 Mar 2026 //
EXPRESSPHARMA
Lilly Finds Impurity in Compounded Version of Weight-loss Drug
12 Mar 2026 //
REUTERS
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
FDA Moves to Address Manufacturing-Related Approval Rejections
10 Mar 2026 //
BIOSPACE
EDQM Approves Anuh Pharma Facility as Audit-Compliant
10 Mar 2026 //
EXPRESSPHARMA
FDA Official Reveals Key GMP Violations In Inspection Reports
09 Mar 2026 //
RAPS
Lupin Gets 2 Observations From USFDA For Ankleshwar Site
09 Mar 2026 //
INDPHARMAPOST
